Krónikus mieloid leukémia (CML) trials, also abroad
190 open Krónikus mieloid leukémia (CML) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Egyesült Államok | 100 |
| Franciaország | 29 |
| Kína | 21 |
| Németország | 19 |
| Olaszország | 19 |
| All other countries |
The same trial often runs in several countries
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia has 1 site in Svédország and runs in 8 countries. If a site near you is full, another one may still take people.
See Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia in all 8 countries